Hunan Fangsheng Pharmaceutical Co., Ltd. logo

Hunan Fangsheng Pharmaceutical Co., Ltd. (603998)

Market Closed
11 Aug, 06:57
SSE SSE
¥
9. 71
-0.03
-0.308%
¥
4B Market Cap
- P/E Ratio
0.2% Div Yield
6.95M Volume
- Eps
¥ 9.74
Previous Close
Add Transaction
Day Range
9.64 9.79
Year Range
8.64 13.5
Want to track 603998 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

603998 closed today lower at ¥9.71, a decrease of -0.308% from yesterday's close, completing a monthly increase of 7.5305% or ¥0.68. Over the past 12 months, 603998 stock lost -13.6121%.
603998 pays dividends to its shareholders, with the most recent payment made on May 29, 2026. The next estimated payment will be in In 2 weeks on Aug 29, 2026 for a total of ¥0.15.
The last earnings report, released on May 14, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Hunan Fangsheng Pharmaceutical Co., Ltd. has completed 2 stock splits, with the recent split occurring on May 05, 2016.
The company's stock is traded on one exchange.

603998 Chart

People also search for

Shanghai Haoyuan Chemexpress Co., Ltd.
¥ 95
-2.7934%
Changchun BCHT Biotechnology Co., Ltd.
¥ 15.91
-0.5003%
Zhejiang Taihua New Material Co., Ltd.
¥ 8.45
+0.1185%
Ningbo Fujia Industrial Co., Ltd.
¥ 14.49
+0.9053%
Xiamen King Long Motor Group Co., Ltd.
¥ 12.16
+0.33%

Hunan Fangsheng Pharmaceutical Co., Ltd. (603998) FAQ

What is the stock price today?

The current price is ¥9.71.

On which exchange is it traded?

Hunan Fangsheng Pharmaceutical Co., Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 603998.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.2%.

What is its market cap?

As of today, the market cap is 4B.

Has Hunan Fangsheng Pharmaceutical Co., Ltd. ever had a stock split?

Hunan Fangsheng Pharmaceutical Co., Ltd. had 2 splits and the recent split was on May 05, 2016.

Hunan Fangsheng Pharmaceutical Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Ms. Xiaoli Zhou CEO
SSE Exchange
CNE100001VG6 ISIN
CN Country
1,686 Employees
29 May 2026 Last Dividend
5 May 2016 Last Split
- IPO Date

Overview

Hunan Fangsheng Pharmaceutical Co., Ltd. is a leading player in the pharmaceutical sector in China, engaged in researching, developing, producing, and selling a wide range of pharmaceutical products. Since its inception in 2002, the company has dedicated itself to addressing diverse medical needs across various therapeutic areas. With its headquarters in Changsha, China, Hunan Fangsheng Pharmaceutical has established a significant presence in the Chinese pharmaceutical market, reflecting its commitment to improving health outcomes and contributing to the well-being of communities.

Products and Services

Hunan Fangsheng Pharmaceutical Co., Ltd. offers an extensive portfolio of pharmaceutical products, designed to cater to a broad spectrum of health conditions. Below are some of the key product categories and their intended uses:

  • Orthopedic Medications: These products are formulated to address various orthopedic conditions, providing relief and treatment for bone, joint, and muscle disorders.
  • Cardiovascular and Cerebrovascular Medications: Aimed at patients suffering from heart and circulatory system diseases, these treatments help manage and prevent conditions affecting the cardiovascular and cerebrovascular systems.
  • Anti-infection Medicines: Focused on combating infections, this range includes antibiotics and antifungal medications that help prevent and treat infections caused by bacteria, viruses, and other pathogens.
  • Pediatric Products: Specially formulated for children, these medicines cater to the unique therapeutic needs of the pediatric population, addressing various health conditions in younger patients.
  • Gynecological Medications: Dedicated to women's health, these products target gynecological disorders, offering treatments for a range of female reproductive system conditions.
  • Respiratory System Medications: Designed to treat respiratory conditions, these medicines help manage diseases affecting the lungs and airways, such as asthma and chronic obstructive pulmonary disease (COPD).
  • Traumatology Products: These are aimed at treating injuries and trauma, providing necessary medical care for acute and chronic conditions resulting from physical injuries.

Contact Information

Address: No. 299, Jiayun Road, Changsha, China, 410205
Phone: 86 731 8899 7188